Organization
Hospital Paulistano and Instituto Américas
1 abstract
Abstract
BELLWAVE-003: A phase 2 dose escalation, confirmation, and cohort expansion study of nemtabrutinib in hematologic malignancies.Org: Hospital Paulistano and Instituto Américas, Tom Baker Cancer Centre, Ankara University School of Medicine, MSC National Research Institute of Oncology, Kraków, Poland, Institut Català d'Oncologia Hospitalet,